Chockalingam, Karuppiah
Peng, Zeyu
Vuong, Christine N.
Berghman, Luc R.
Chen, Zhilei http://orcid.org/0000-0002-0244-3556
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP160827)
Article History
Received: 3 November 2019
Accepted: 3 February 2020
First Online: 19 February 2020
Competing interests
: A patent application on the anti-hCD20 mAbs AC1 and AC11 will be submitted through Texas A&M University.